Come up with a name for your new list and we'll add to it:
IP Pharmaceuticals raised a round of funding on , . Investors include
Advanced Science & Tech Commercialization Center.
IP Pharmaceuticals develops technologies and reagents for antiviral drug discovery focusing on therapeutics and vaccines to treat infectious diseases caused by viruses such as hepatitis, influenza, We…